Clinical Trials Browser

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Carcinoma, Renal Cell, Melanoma, Neoplasms, Skin Neoplasms, Urologic Neoplasms

Melanoma, Neoplasms, Skin Neoplasms

Melanoma, Neoplasms, Skin Neoplasms

Melanoma, Neoplasm Metastasis, Skin Neoplasms

Melanoma, Skin Neoplasms

Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Neoplasms, Skin Neoplasms

Melanoma, Skin Neoplasms

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

Carcinoma, Basal Cell, Skin Neoplasms

Melanoma, Melanoma, Experimental, Neoplasms, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Melanoma, Skin Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Skin Neoplasms

Clinical Trials

A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...

flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma

Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma

Lapatinib in Stage IV Melanoma With ERBB4 Mutations

Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer

Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Drosophila-generated CTL

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant

Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma

Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma

Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma

Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells

Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes

Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes

LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck